CN109293742B - Polypeptide for identifying donkey-hide gelatin and mule skin-derived component in donkey-hide gelatin product - Google Patents
Polypeptide for identifying donkey-hide gelatin and mule skin-derived component in donkey-hide gelatin product Download PDFInfo
- Publication number
- CN109293742B CN109293742B CN201811245616.XA CN201811245616A CN109293742B CN 109293742 B CN109293742 B CN 109293742B CN 201811245616 A CN201811245616 A CN 201811245616A CN 109293742 B CN109293742 B CN 109293742B
- Authority
- CN
- China
- Prior art keywords
- seq
- donkey
- peptide fragment
- mule
- hide
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 108010010803 Gelatin Proteins 0.000 title claims abstract description 117
- 239000008273 gelatin Substances 0.000 title claims abstract description 117
- 229920000159 gelatin Polymers 0.000 title claims abstract description 117
- 235000019322 gelatine Nutrition 0.000 title claims abstract description 117
- 235000011852 gelatine desserts Nutrition 0.000 title claims abstract description 117
- 108090000765 processed proteins & peptides Proteins 0.000 title claims abstract description 101
- 241001331845 Equus asinus x caballus Species 0.000 title claims abstract description 77
- 102000004196 processed proteins & peptides Human genes 0.000 title claims abstract description 77
- 229920001184 polypeptide Polymers 0.000 title claims abstract description 76
- 241000283073 Equus caballus Species 0.000 claims abstract description 25
- 241000283074 Equus asinus Species 0.000 claims abstract description 17
- 238000000034 method Methods 0.000 claims abstract description 15
- 238000004949 mass spectrometry Methods 0.000 claims abstract description 8
- 102000007079 Peptide Fragments Human genes 0.000 claims description 154
- 108010033276 Peptide Fragments Proteins 0.000 claims description 154
- 238000001819 mass spectrum Methods 0.000 claims description 44
- 238000001514 detection method Methods 0.000 claims description 35
- 239000000047 product Substances 0.000 claims description 23
- 239000000706 filtrate Substances 0.000 claims description 12
- 108010052008 colla corii asini Proteins 0.000 claims description 11
- XBJFCYDKBDVADW-UHFFFAOYSA-N acetonitrile;formic acid Chemical compound CC#N.OC=O XBJFCYDKBDVADW-UHFFFAOYSA-N 0.000 claims description 8
- HQVFCQRVQFYGRJ-UHFFFAOYSA-N formic acid;hydrate Chemical compound O.OC=O HQVFCQRVQFYGRJ-UHFFFAOYSA-N 0.000 claims description 8
- 102000004142 Trypsin Human genes 0.000 claims description 7
- 108090000631 Trypsin Proteins 0.000 claims description 7
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 claims description 5
- 239000000463 material Substances 0.000 claims description 5
- 239000008280 blood Substances 0.000 claims description 4
- 210000004369 blood Anatomy 0.000 claims description 4
- 238000001914 filtration Methods 0.000 claims description 4
- 239000012528 membrane Substances 0.000 claims description 4
- 239000000843 powder Substances 0.000 claims description 4
- 238000005173 quadrupole mass spectroscopy Methods 0.000 claims description 4
- 239000007921 spray Substances 0.000 claims description 4
- 238000009210 therapy by ultrasound Methods 0.000 claims description 4
- 238000012546 transfer Methods 0.000 claims description 4
- 238000005303 weighing Methods 0.000 claims description 4
- 239000007788 liquid Substances 0.000 claims description 2
- 239000002002 slurry Substances 0.000 claims description 2
- 235000000346 sugar Nutrition 0.000 claims description 2
- 239000008187 granular material Substances 0.000 claims 1
- 238000002360 preparation method Methods 0.000 claims 1
- 239000003292 glue Substances 0.000 abstract description 69
- 150000002500 ions Chemical class 0.000 abstract description 18
- 241000283690 Bos taurus Species 0.000 description 9
- VPZXBVLAVMBEQI-UHFFFAOYSA-N glycyl-DL-alpha-alanine Natural products OC(=O)C(C)NC(=O)CN VPZXBVLAVMBEQI-UHFFFAOYSA-N 0.000 description 7
- 238000010586 diagram Methods 0.000 description 6
- 241001465754 Metazoa Species 0.000 description 5
- 108010047495 alanylglycine Proteins 0.000 description 5
- 239000010985 leather Substances 0.000 description 5
- SCAKQYSGEIHPLV-IUCAKERBSA-N (4S)-4-[(2-aminoacetyl)amino]-5-[(2S)-2-(carboxymethylcarbamoyl)pyrrolidin-1-yl]-5-oxopentanoic acid Chemical compound NCC(=O)N[C@@H](CCC(O)=O)C(=O)N1CCC[C@H]1C(=O)NCC(O)=O SCAKQYSGEIHPLV-IUCAKERBSA-N 0.000 description 4
- 108010079364 N-glycylalanine Proteins 0.000 description 4
- KAJAOGBVWCYGHZ-JTQLQIEISA-N Gly-Gly-Phe Chemical compound [NH3+]CC(=O)NCC(=O)N[C@H](C([O-])=O)CC1=CC=CC=C1 KAJAOGBVWCYGHZ-JTQLQIEISA-N 0.000 description 3
- YWAQATDNEKZFFK-BYPYZUCNSA-N Gly-Gly-Ser Chemical compound NCC(=O)NCC(=O)N[C@@H](CO)C(O)=O YWAQATDNEKZFFK-BYPYZUCNSA-N 0.000 description 3
- GGAPHLIUUTVYMX-QWRGUYRKSA-N Gly-Phe-Ser Chemical compound OC[C@@H](C([O-])=O)NC(=O)[C@@H](NC(=O)C[NH3+])CC1=CC=CC=C1 GGAPHLIUUTVYMX-QWRGUYRKSA-N 0.000 description 3
- SRSPTFBENMJHMR-WHFBIAKZSA-N Ser-Ser-Gly Chemical compound OC[C@H](N)C(=O)N[C@@H](CO)C(=O)NCC(O)=O SRSPTFBENMJHMR-WHFBIAKZSA-N 0.000 description 3
- JVGHIFMSFBZDHH-WPRPVWTQSA-N Val-Met-Gly Chemical compound CC(C)[C@@H](C(=O)N[C@@H](CCSC)C(=O)NCC(=O)O)N JVGHIFMSFBZDHH-WPRPVWTQSA-N 0.000 description 3
- 108010073093 leucyl-glycyl-glycyl-glycine Proteins 0.000 description 3
- 108010051242 phenylalanylserine Proteins 0.000 description 3
- 238000012216 screening Methods 0.000 description 3
- 238000001228 spectrum Methods 0.000 description 3
- 108010061238 threonyl-glycine Proteins 0.000 description 3
- KIUYPHAMDKDICO-WHFBIAKZSA-N Ala-Asp-Gly Chemical compound C[C@H](N)C(=O)N[C@@H](CC(O)=O)C(=O)NCC(O)=O KIUYPHAMDKDICO-WHFBIAKZSA-N 0.000 description 2
- ZVFVBBGVOILKPO-WHFBIAKZSA-N Ala-Gly-Ala Chemical compound C[C@H](N)C(=O)NCC(=O)N[C@@H](C)C(O)=O ZVFVBBGVOILKPO-WHFBIAKZSA-N 0.000 description 2
- GKKUBLFXKRDMFC-BQBZGAKWSA-N Asn-Pro-Gly Chemical compound [H]N[C@@H](CC(N)=O)C(=O)N1CCC[C@H]1C(=O)NCC(O)=O GKKUBLFXKRDMFC-BQBZGAKWSA-N 0.000 description 2
- AWXDRZJQCVHCIT-DCAQKATOSA-N Asn-Pro-Lys Chemical compound NCCCC[C@@H](C(O)=O)NC(=O)[C@@H]1CCCN1C(=O)[C@@H](N)CC(N)=O AWXDRZJQCVHCIT-DCAQKATOSA-N 0.000 description 2
- PZXPWHFYZXTFBI-YUMQZZPRSA-N Asp-Gly-Lys Chemical compound NCCCC[C@@H](C(O)=O)NC(=O)CNC(=O)[C@@H](N)CC(O)=O PZXPWHFYZXTFBI-YUMQZZPRSA-N 0.000 description 2
- PLNJUJGNLDSFOP-UWJYBYFXSA-N Asp-Tyr-Ala Chemical compound [H]N[C@@H](CC(O)=O)C(=O)N[C@@H](CC1=CC=C(O)C=C1)C(=O)N[C@@H](C)C(O)=O PLNJUJGNLDSFOP-UWJYBYFXSA-N 0.000 description 2
- FQCILXROGNOZON-YUMQZZPRSA-N Gln-Pro-Gly Chemical compound NC(=O)CC[C@H](N)C(=O)N1CCC[C@H]1C(=O)NCC(O)=O FQCILXROGNOZON-YUMQZZPRSA-N 0.000 description 2
- QGWXAMDECCKGRU-XVKPBYJWSA-N Gln-Val-Gly Chemical compound CC(C)[C@H](NC(=O)[C@@H](N)CCC(N)=O)C(=O)NCC(O)=O QGWXAMDECCKGRU-XVKPBYJWSA-N 0.000 description 2
- UTKUTMJSWKKHEM-WDSKDSINSA-N Glu-Ala-Gly Chemical compound OC(=O)CNC(=O)[C@H](C)NC(=O)[C@@H](N)CCC(O)=O UTKUTMJSWKKHEM-WDSKDSINSA-N 0.000 description 2
- XTZDZAXYPDISRR-MNXVOIDGSA-N Glu-Ile-Lys Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H](CCCCN)C(=O)O)NC(=O)[C@H](CCC(=O)O)N XTZDZAXYPDISRR-MNXVOIDGSA-N 0.000 description 2
- VMKCPNBBPGGQBJ-GUBZILKMSA-N Glu-Leu-Asn Chemical compound CC(C)C[C@@H](C(=O)N[C@@H](CC(=O)N)C(=O)O)NC(=O)[C@H](CCC(=O)O)N VMKCPNBBPGGQBJ-GUBZILKMSA-N 0.000 description 2
- GMVCSRBOSIUTFC-FXQIFTODSA-N Glu-Ser-Glu Chemical compound [H]N[C@@H](CCC(O)=O)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCC(O)=O)C(O)=O GMVCSRBOSIUTFC-FXQIFTODSA-N 0.000 description 2
- PUUYVMYCMIWHFE-BQBZGAKWSA-N Gly-Ala-Arg Chemical compound NCC(=O)N[C@@H](C)C(=O)N[C@H](C(O)=O)CCCN=C(N)N PUUYVMYCMIWHFE-BQBZGAKWSA-N 0.000 description 2
- DHDOADIPGZTAHT-YUMQZZPRSA-N Gly-Glu-Arg Chemical compound NCC(=O)N[C@@H](CCC(O)=O)C(=O)N[C@H](C(O)=O)CCCN=C(N)N DHDOADIPGZTAHT-YUMQZZPRSA-N 0.000 description 2
- UHPAZODVFFYEEL-QWRGUYRKSA-N Gly-Leu-Leu Chemical compound CC(C)C[C@@H](C(O)=O)NC(=O)[C@H](CC(C)C)NC(=O)CN UHPAZODVFFYEEL-QWRGUYRKSA-N 0.000 description 2
- CAVKXZMMDNOZJU-UHFFFAOYSA-N Gly-Pro-Ala-Gly-Pro Natural products C1CCC(C(O)=O)N1C(=O)CNC(=O)C(C)NC(=O)C1CCCN1C(=O)CN CAVKXZMMDNOZJU-UHFFFAOYSA-N 0.000 description 2
- BMWFDYIYBAFROD-WPRPVWTQSA-N Gly-Pro-Val Chemical compound CC(C)[C@@H](C(O)=O)NC(=O)[C@@H]1CCCN1C(=O)CN BMWFDYIYBAFROD-WPRPVWTQSA-N 0.000 description 2
- SOEGEPHNZOISMT-BYPYZUCNSA-N Gly-Ser-Gly Chemical compound NCC(=O)N[C@@H](CO)C(=O)NCC(O)=O SOEGEPHNZOISMT-BYPYZUCNSA-N 0.000 description 2
- WNGHUXFWEWTKAO-YUMQZZPRSA-N Gly-Ser-Leu Chemical compound CC(C)C[C@@H](C(O)=O)NC(=O)[C@H](CO)NC(=O)CN WNGHUXFWEWTKAO-YUMQZZPRSA-N 0.000 description 2
- ZMYHJISLFYTQGK-FXQIFTODSA-N Met-Asp-Asn Chemical compound [H]N[C@@H](CCSC)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CC(N)=O)C(O)=O ZMYHJISLFYTQGK-FXQIFTODSA-N 0.000 description 2
- KZNQNBZMBZJQJO-UHFFFAOYSA-N N-glycyl-L-proline Natural products NCC(=O)N1CCCC1C(O)=O KZNQNBZMBZJQJO-UHFFFAOYSA-N 0.000 description 2
- WEDZFLRYSIDIRX-IHRRRGAJSA-N Phe-Ser-Arg Chemical compound NC(=N)NCCC[C@@H](C(O)=O)NC(=O)[C@H](CO)NC(=O)[C@@H](N)CC1=CC=CC=C1 WEDZFLRYSIDIRX-IHRRRGAJSA-N 0.000 description 2
- KIZQGKLMXKGDIV-BQBZGAKWSA-N Pro-Ala-Gly Chemical compound OC(=O)CNC(=O)[C@H](C)NC(=O)[C@@H]1CCCN1 KIZQGKLMXKGDIV-BQBZGAKWSA-N 0.000 description 2
- CLNJSLSHKJECME-BQBZGAKWSA-N Pro-Gly-Ala Chemical compound OC(=O)[C@H](C)NC(=O)CNC(=O)[C@@H]1CCCN1 CLNJSLSHKJECME-BQBZGAKWSA-N 0.000 description 2
- LEIKGVHQTKHOLM-IUCAKERBSA-N Pro-Pro-Gly Chemical compound OC(=O)CNC(=O)[C@@H]1CCCN1C(=O)[C@H]1NCCC1 LEIKGVHQTKHOLM-IUCAKERBSA-N 0.000 description 2
- MSIYNSBKKVMGFO-BHNWBGBOSA-N Thr-Gly-Pro Chemical compound C[C@H]([C@@H](C(=O)NCC(=O)N1CCC[C@@H]1C(=O)O)N)O MSIYNSBKKVMGFO-BHNWBGBOSA-N 0.000 description 2
- VHIZXDZMTDVFGX-DCAQKATOSA-N Val-Ser-Leu Chemical compound CC(C)C[C@@H](C(=O)O)NC(=O)[C@H](CO)NC(=O)[C@H](C(C)C)N VHIZXDZMTDVFGX-DCAQKATOSA-N 0.000 description 2
- 108010005233 alanylglutamic acid Proteins 0.000 description 2
- 108010044940 alanylglutamine Proteins 0.000 description 2
- 238000004458 analytical method Methods 0.000 description 2
- 239000003814 drug Substances 0.000 description 2
- 238000005516 engineering process Methods 0.000 description 2
- 108010042598 glutamyl-aspartyl-glycine Proteins 0.000 description 2
- 108010077435 glycyl-phenylalanyl-glycine Proteins 0.000 description 2
- 239000004615 ingredient Substances 0.000 description 2
- 108010014614 prolyl-glycyl-proline Proteins 0.000 description 2
- 108010029020 prolylglycine Proteins 0.000 description 2
- 108090000623 proteins and genes Proteins 0.000 description 2
- 102000004169 proteins and genes Human genes 0.000 description 2
- RLMISHABBKUNFO-WHFBIAKZSA-N Ala-Ala-Gly Chemical compound C[C@H](N)C(=O)N[C@@H](C)C(=O)NCC(O)=O RLMISHABBKUNFO-WHFBIAKZSA-N 0.000 description 1
- FUSPCLTUKXQREV-ACZMJKKPSA-N Ala-Glu-Ala Chemical compound [H]N[C@@H](C)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](C)C(O)=O FUSPCLTUKXQREV-ACZMJKKPSA-N 0.000 description 1
- MQIGTEQXYCRLGK-BQBZGAKWSA-N Ala-Gly-Pro Chemical compound C[C@H](N)C(=O)NCC(=O)N1CCC[C@H]1C(O)=O MQIGTEQXYCRLGK-BQBZGAKWSA-N 0.000 description 1
- OBVSBEYOMDWLRJ-BFHQHQDPSA-N Ala-Gly-Thr Chemical compound C[C@@H](O)[C@@H](C(O)=O)NC(=O)CNC(=O)[C@H](C)N OBVSBEYOMDWLRJ-BFHQHQDPSA-N 0.000 description 1
- QRIYOHQJRDHFKF-UWJYBYFXSA-N Ala-Tyr-Ser Chemical compound OC[C@@H](C(O)=O)NC(=O)[C@@H](NC(=O)[C@@H](N)C)CC1=CC=C(O)C=C1 QRIYOHQJRDHFKF-UWJYBYFXSA-N 0.000 description 1
- QJMCHPGWFZZRID-BQBZGAKWSA-N Asn-Lys Chemical compound NCCCC[C@@H](C(O)=O)NC(=O)[C@@H](N)CC(N)=O QJMCHPGWFZZRID-BQBZGAKWSA-N 0.000 description 1
- VHQSGALUSWIYOD-QXEWZRGKSA-N Asn-Pro-Val Chemical compound [H]N[C@@H](CC(N)=O)C(=O)N1CCC[C@H]1C(=O)N[C@@H](C(C)C)C(O)=O VHQSGALUSWIYOD-QXEWZRGKSA-N 0.000 description 1
- ZSJFGGSPCCHMNE-LAEOZQHASA-N Asp-Gln-Val Chemical compound CC(C)[C@@H](C(=O)O)NC(=O)[C@H](CCC(=O)N)NC(=O)[C@H](CC(=O)O)N ZSJFGGSPCCHMNE-LAEOZQHASA-N 0.000 description 1
- PDECQIHABNQRHN-GUBZILKMSA-N Asp-Glu-Leu Chemical compound CC(C)C[C@@H](C(O)=O)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@@H](N)CC(O)=O PDECQIHABNQRHN-GUBZILKMSA-N 0.000 description 1
- YNCHFVRXEQFPBY-BQBZGAKWSA-N Asp-Gly-Arg Chemical compound OC(=O)C[C@H](N)C(=O)NCC(=O)N[C@H](C(O)=O)CCCN=C(N)N YNCHFVRXEQFPBY-BQBZGAKWSA-N 0.000 description 1
- SEMWSADZTMJELF-BYULHYEWSA-N Asp-Ile-Gly Chemical compound [H]N[C@@H](CC(O)=O)C(=O)N[C@@H]([C@@H](C)CC)C(=O)NCC(O)=O SEMWSADZTMJELF-BYULHYEWSA-N 0.000 description 1
- UMHUHHJMEXNSIV-CIUDSAMLSA-N Asp-Leu-Ser Chemical compound OC[C@@H](C(O)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)CC(O)=O UMHUHHJMEXNSIV-CIUDSAMLSA-N 0.000 description 1
- LBOVBQONZJRWPV-YUMQZZPRSA-N Asp-Lys-Gly Chemical compound [H]N[C@@H](CC(O)=O)C(=O)N[C@@H](CCCCN)C(=O)NCC(O)=O LBOVBQONZJRWPV-YUMQZZPRSA-N 0.000 description 1
- 241000283086 Equidae Species 0.000 description 1
- XJKAKYXMFHUIHT-AUTRQRHGSA-N Gln-Glu-Val Chemical compound CC(C)[C@@H](C(=O)O)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CCC(=O)N)N XJKAKYXMFHUIHT-AUTRQRHGSA-N 0.000 description 1
- QKCZZAZNMMVICF-DCAQKATOSA-N Gln-Leu-Glu Chemical compound NC(=O)CC[C@H](N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(O)=O)C(O)=O QKCZZAZNMMVICF-DCAQKATOSA-N 0.000 description 1
- OPAINBJQDQTGJY-JGVFFNPUSA-N Glu-Gly-Pro Chemical compound C1C[C@@H](N(C1)C(=O)CNC(=O)[C@H](CCC(=O)O)N)C(=O)O OPAINBJQDQTGJY-JGVFFNPUSA-N 0.000 description 1
- TZXOPHFCAATANZ-QEJZJMRPSA-N Glu-Ser-Trp Chemical compound C1=CC=C2C(=C1)C(=CN2)C[C@@H](C(=O)O)NC(=O)[C@H](CO)NC(=O)[C@H](CCC(=O)O)N TZXOPHFCAATANZ-QEJZJMRPSA-N 0.000 description 1
- HZISRJBYZAODRV-XQXXSGGOSA-N Glu-Thr-Ala Chemical compound [H]N[C@@H](CCC(O)=O)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C)C(O)=O HZISRJBYZAODRV-XQXXSGGOSA-N 0.000 description 1
- VXEFAWJTFAUDJK-AVGNSLFASA-N Glu-Tyr-Ser Chemical compound C1=CC(=CC=C1C[C@@H](C(=O)N[C@@H](CO)C(=O)O)NC(=O)[C@H](CCC(=O)O)N)O VXEFAWJTFAUDJK-AVGNSLFASA-N 0.000 description 1
- PYTZFYUXZZHOAD-WHFBIAKZSA-N Gly-Ala-Ala Chemical compound OC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)CN PYTZFYUXZZHOAD-WHFBIAKZSA-N 0.000 description 1
- GNPVTZJUUBPZKW-WDSKDSINSA-N Gly-Gln-Ser Chemical compound [H]NCC(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CO)C(O)=O GNPVTZJUUBPZKW-WDSKDSINSA-N 0.000 description 1
- MBOAPAXLTUSMQI-JHEQGTHGSA-N Gly-Glu-Thr Chemical compound [H]NCC(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H]([C@@H](C)O)C(O)=O MBOAPAXLTUSMQI-JHEQGTHGSA-N 0.000 description 1
- UUYBFNKHOCJCHT-VHSXEESVSA-N Gly-Leu-Pro Chemical compound CC(C)C[C@@H](C(=O)N1CCC[C@@H]1C(=O)O)NC(=O)CN UUYBFNKHOCJCHT-VHSXEESVSA-N 0.000 description 1
- IGOYNRWLWHWAQO-JTQLQIEISA-N Gly-Phe-Gly Chemical compound OC(=O)CNC(=O)[C@@H](NC(=O)CN)CC1=CC=CC=C1 IGOYNRWLWHWAQO-JTQLQIEISA-N 0.000 description 1
- GGLIDLCEPDHEJO-BQBZGAKWSA-N Gly-Pro-Ala Chemical compound OC(=O)[C@H](C)NC(=O)[C@@H]1CCCN1C(=O)CN GGLIDLCEPDHEJO-BQBZGAKWSA-N 0.000 description 1
- JYPCXBJRLBHWME-IUCAKERBSA-N Gly-Pro-Arg Chemical compound NCC(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCNC(N)=N)C(O)=O JYPCXBJRLBHWME-IUCAKERBSA-N 0.000 description 1
- OOCFXNOVSLSHAB-IUCAKERBSA-N Gly-Pro-Pro Chemical compound NCC(=O)N1CCC[C@H]1C(=O)N1[C@H](C(O)=O)CCC1 OOCFXNOVSLSHAB-IUCAKERBSA-N 0.000 description 1
- HAOUOFNNJJLVNS-BQBZGAKWSA-N Gly-Pro-Ser Chemical compound NCC(=O)N1CCC[C@H]1C(=O)N[C@@H](CO)C(O)=O HAOUOFNNJJLVNS-BQBZGAKWSA-N 0.000 description 1
- ZLCLYFGMKFCDCN-XPUUQOCRSA-N Gly-Ser-Val Chemical compound CC(C)[C@H](NC(=O)[C@H](CO)NC(=O)CN)C(O)=O ZLCLYFGMKFCDCN-XPUUQOCRSA-N 0.000 description 1
- YGHSQRJSHKYUJY-SCZZXKLOSA-N Gly-Val-Pro Chemical compound CC(C)[C@@H](C(=O)N1CCC[C@@H]1C(=O)O)NC(=O)CN YGHSQRJSHKYUJY-SCZZXKLOSA-N 0.000 description 1
- JBCLFWXMTIKCCB-UHFFFAOYSA-N H-Gly-Phe-OH Natural products NCC(=O)NC(C(O)=O)CC1=CC=CC=C1 JBCLFWXMTIKCCB-UHFFFAOYSA-N 0.000 description 1
- DCRODRAURLJOFY-XPUUQOCRSA-N His-Ala-Gly Chemical compound [H]N[C@@H](CC1=CNC=N1)C(=O)N[C@@H](C)C(=O)NCC(O)=O DCRODRAURLJOFY-XPUUQOCRSA-N 0.000 description 1
- BDFCIKANUNMFGB-PMVVWTBXSA-N His-Gly-Thr Chemical compound C[C@@H](O)[C@@H](C(O)=O)NC(=O)CNC(=O)[C@@H](N)CC1=CN=CN1 BDFCIKANUNMFGB-PMVVWTBXSA-N 0.000 description 1
- KLBVGHCGHUNHEA-BJDJZHNGSA-N Ile-Leu-Ala Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)O)N KLBVGHCGHUNHEA-BJDJZHNGSA-N 0.000 description 1
- OUUCIIJSBIBCHB-ZPFDUUQYSA-N Ile-Leu-Asp Chemical compound CC[C@H](C)[C@H](N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(O)=O)C(O)=O OUUCIIJSBIBCHB-ZPFDUUQYSA-N 0.000 description 1
- DSDPLOODKXISDT-XUXIUFHCSA-N Ile-Leu-Val Chemical compound CC[C@H](C)[C@H](N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C(C)C)C(O)=O DSDPLOODKXISDT-XUXIUFHCSA-N 0.000 description 1
- ZLFNNVATRMCAKN-ZKWXMUAHSA-N Ile-Ser-Gly Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H](CO)C(=O)NCC(=O)O)N ZLFNNVATRMCAKN-ZKWXMUAHSA-N 0.000 description 1
- LHSGPCFBGJHPCY-UHFFFAOYSA-N L-leucine-L-tyrosine Natural products CC(C)CC(N)C(=O)NC(C(O)=O)CC1=CC=C(O)C=C1 LHSGPCFBGJHPCY-UHFFFAOYSA-N 0.000 description 1
- TYYLDKGBCJGJGW-UHFFFAOYSA-N L-tryptophan-L-tyrosine Natural products C=1NC2=CC=CC=C2C=1CC(N)C(=O)NC(C(O)=O)CC1=CC=C(O)C=C1 TYYLDKGBCJGJGW-UHFFFAOYSA-N 0.000 description 1
- CIVKXGPFXDIQBV-WDCWCFNPSA-N Leu-Gln-Thr Chemical compound CC(C)C[C@H](N)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H]([C@@H](C)O)C(O)=O CIVKXGPFXDIQBV-WDCWCFNPSA-N 0.000 description 1
- HNDWYLYAYNBWMP-AJNGGQMLSA-N Leu-Ile-Lys Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H](CCCCN)C(=O)O)NC(=O)[C@H](CC(C)C)N HNDWYLYAYNBWMP-AJNGGQMLSA-N 0.000 description 1
- QMKFDEUJGYNFMC-AVGNSLFASA-N Leu-Pro-Arg Chemical compound CC(C)C[C@H](N)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCN=C(N)N)C(O)=O QMKFDEUJGYNFMC-AVGNSLFASA-N 0.000 description 1
- PWPBLZXWFXJFHE-RHYQMDGZSA-N Leu-Pro-Thr Chemical compound CC(C)C[C@H](N)C(=O)N1CCC[C@H]1C(=O)N[C@@H]([C@@H](C)O)C(O)=O PWPBLZXWFXJFHE-RHYQMDGZSA-N 0.000 description 1
- QWWPYKKLXWOITQ-VOAKCMCISA-N Leu-Thr-Leu Chemical compound CC(C)C[C@H](N)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@H](C(O)=O)CC(C)C QWWPYKKLXWOITQ-VOAKCMCISA-N 0.000 description 1
- PDIDTSZKKFEDMB-UWVGGRQHSA-N Lys-Pro-Gly Chemical compound [H]N[C@@H](CCCCN)C(=O)N1CCC[C@H]1C(=O)NCC(O)=O PDIDTSZKKFEDMB-UWVGGRQHSA-N 0.000 description 1
- SJDQOYTYNGZZJX-SRVKXCTJSA-N Met-Glu-Leu Chemical compound CSCC[C@H](N)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC(C)C)C(O)=O SJDQOYTYNGZZJX-SRVKXCTJSA-N 0.000 description 1
- AJHCSUXXECOXOY-UHFFFAOYSA-N N-glycyl-L-tryptophan Natural products C1=CC=C2C(CC(NC(=O)CN)C(O)=O)=CNC2=C1 AJHCSUXXECOXOY-UHFFFAOYSA-N 0.000 description 1
- 108010002311 N-glycylglutamic acid Proteins 0.000 description 1
- FPTXMUIBLMGTQH-ONGXEEELSA-N Phe-Ala-Gly Chemical compound OC(=O)CNC(=O)[C@H](C)NC(=O)[C@@H](N)CC1=CC=CC=C1 FPTXMUIBLMGTQH-ONGXEEELSA-N 0.000 description 1
- KAJLHCWRWDSROH-BZSNNMDCSA-N Phe-Phe-Asp Chemical compound C([C@H](N)C(=O)N[C@@H](CC=1C=CC=CC=1)C(=O)N[C@@H](CC(O)=O)C(O)=O)C1=CC=CC=C1 KAJLHCWRWDSROH-BZSNNMDCSA-N 0.000 description 1
- DEDANIDYQAPTFI-IHRRRGAJSA-N Pro-Asp-Tyr Chemical compound [H]N1CCC[C@H]1C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CC1=CC=C(O)C=C1)C(O)=O DEDANIDYQAPTFI-IHRRRGAJSA-N 0.000 description 1
- LXVLKXPFIDDHJG-CIUDSAMLSA-N Pro-Glu-Ser Chemical compound [H]N1CCC[C@H]1C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CO)C(O)=O LXVLKXPFIDDHJG-CIUDSAMLSA-N 0.000 description 1
- FEPSEIDIPBMIOS-QXEWZRGKSA-N Pro-Gly-Ile Chemical compound CC[C@H](C)[C@@H](C(O)=O)NC(=O)CNC(=O)[C@@H]1CCCN1 FEPSEIDIPBMIOS-QXEWZRGKSA-N 0.000 description 1
- ZMLRZBWCXPQADC-TUAOUCFPSA-N Pro-Val-Pro Chemical compound CC(C)[C@@H](C(=O)N1CCC[C@@H]1C(=O)O)NC(=O)[C@@H]2CCCN2 ZMLRZBWCXPQADC-TUAOUCFPSA-N 0.000 description 1
- RZEQTVHJZCIUBT-WDSKDSINSA-N Ser-Arg Chemical compound OC[C@H](N)C(=O)N[C@H](C(O)=O)CCCNC(N)=N RZEQTVHJZCIUBT-WDSKDSINSA-N 0.000 description 1
- YMTLKLXDFCSCNX-BYPYZUCNSA-N Ser-Gly-Gly Chemical compound OC[C@H](N)C(=O)NCC(=O)NCC(O)=O YMTLKLXDFCSCNX-BYPYZUCNSA-N 0.000 description 1
- JFWDJFULOLKQFY-QWRGUYRKSA-N Ser-Gly-Phe Chemical compound [H]N[C@@H](CO)C(=O)NCC(=O)N[C@@H](CC1=CC=CC=C1)C(O)=O JFWDJFULOLKQFY-QWRGUYRKSA-N 0.000 description 1
- KDGARKCAKHBEDB-NKWVEPMBSA-N Ser-Gly-Pro Chemical compound C1C[C@@H](N(C1)C(=O)CNC(=O)[C@H](CO)N)C(=O)O KDGARKCAKHBEDB-NKWVEPMBSA-N 0.000 description 1
- XNCUYZKGQOCOQH-YUMQZZPRSA-N Ser-Leu-Gly Chemical compound [H]N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)NCC(O)=O XNCUYZKGQOCOQH-YUMQZZPRSA-N 0.000 description 1
- XKFJENWJGHMDLI-QWRGUYRKSA-N Ser-Phe-Gly Chemical compound [H]N[C@@H](CO)C(=O)N[C@@H](CC1=CC=CC=C1)C(=O)NCC(O)=O XKFJENWJGHMDLI-QWRGUYRKSA-N 0.000 description 1
- XQJCEKXQUJQNNK-ZLUOBGJFSA-N Ser-Ser-Ser Chemical compound OC[C@H](N)C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(O)=O XQJCEKXQUJQNNK-ZLUOBGJFSA-N 0.000 description 1
- HQJOVVWAPQPYDS-ZFWWWQNUSA-N Trp-Gly-Arg Chemical compound [H]N[C@@H](CC1=CNC2=C1C=CC=C2)C(=O)NCC(=O)N[C@@H](CCCNC(N)=N)C(O)=O HQJOVVWAPQPYDS-ZFWWWQNUSA-N 0.000 description 1
- UUZYQOUJTORBQO-ZVZYQTTQSA-N Trp-Val-Gln Chemical compound C1=CC=C2C(C[C@H](N)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCC(N)=O)C(O)=O)=CNC2=C1 UUZYQOUJTORBQO-ZVZYQTTQSA-N 0.000 description 1
- HZZKQZDUIKVFDZ-AVGNSLFASA-N Tyr-Gln-Ser Chemical compound C1=CC(=CC=C1C[C@@H](C(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H](CO)C(=O)O)N)O HZZKQZDUIKVFDZ-AVGNSLFASA-N 0.000 description 1
- BSCBBPKDVOZICB-KKUMJFAQSA-N Tyr-Leu-Asp Chemical compound [H]N[C@@H](CC1=CC=C(O)C=C1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(O)=O)C(O)=O BSCBBPKDVOZICB-KKUMJFAQSA-N 0.000 description 1
- UMSZZGTXGKHTFJ-SRVKXCTJSA-N Tyr-Ser-Ser Chemical compound OC[C@@H](C(O)=O)NC(=O)[C@H](CO)NC(=O)[C@@H](N)CC1=CC=C(O)C=C1 UMSZZGTXGKHTFJ-SRVKXCTJSA-N 0.000 description 1
- URIRWLJVWHYLET-ONGXEEELSA-N Val-Gly-Leu Chemical compound CC(C)C[C@@H](C(O)=O)NC(=O)CNC(=O)[C@@H](N)C(C)C URIRWLJVWHYLET-ONGXEEELSA-N 0.000 description 1
- BVWPHWLFGRCECJ-JSGCOSHPSA-N Val-Gly-Tyr Chemical compound CC(C)[C@@H](C(=O)NCC(=O)N[C@@H](CC1=CC=C(C=C1)O)C(=O)O)N BVWPHWLFGRCECJ-JSGCOSHPSA-N 0.000 description 1
- UXODSMTVPWXHBT-ULQDDVLXSA-N Val-Phe-His Chemical compound CC(C)[C@@H](C(=O)N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H](CC2=CN=CN2)C(=O)O)N UXODSMTVPWXHBT-ULQDDVLXSA-N 0.000 description 1
- SSYBNWFXCFNRFN-GUBZILKMSA-N Val-Pro-Ser Chemical compound CC(C)[C@H](N)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CO)C(O)=O SSYBNWFXCFNRFN-GUBZILKMSA-N 0.000 description 1
- UGFMVXRXULGLNO-XPUUQOCRSA-N Val-Ser-Gly Chemical compound CC(C)[C@H](N)C(=O)N[C@@H](CO)C(=O)NCC(O)=O UGFMVXRXULGLNO-XPUUQOCRSA-N 0.000 description 1
- 230000032683 aging Effects 0.000 description 1
- 108010068380 arginylarginine Proteins 0.000 description 1
- 230000000740 bleeding effect Effects 0.000 description 1
- 229910052799 carbon Inorganic materials 0.000 description 1
- 235000009508 confectionery Nutrition 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 230000018109 developmental process Effects 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 235000013305 food Nutrition 0.000 description 1
- 239000012634 fragment Substances 0.000 description 1
- 108010063718 gamma-glutamylaspartic acid Proteins 0.000 description 1
- 108010027668 glycyl-alanyl-valine Proteins 0.000 description 1
- 108010062266 glycyl-glycyl-argininal Proteins 0.000 description 1
- 108010074027 glycyl-seryl-phenylalanine Proteins 0.000 description 1
- 108010020688 glycylhistidine Proteins 0.000 description 1
- 108010050848 glycylleucine Proteins 0.000 description 1
- 108010084389 glycyltryptophan Proteins 0.000 description 1
- 241000411851 herbal medicine Species 0.000 description 1
- 235000008216 herbs Nutrition 0.000 description 1
- 230000036039 immunity Effects 0.000 description 1
- 238000007689 inspection Methods 0.000 description 1
- 210000003734 kidney Anatomy 0.000 description 1
- 235000021190 leftovers Nutrition 0.000 description 1
- 108010012058 leucyltyrosine Proteins 0.000 description 1
- 210000004185 liver Anatomy 0.000 description 1
- 210000004072 lung Anatomy 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 239000002398 materia medica Substances 0.000 description 1
- 239000003973 paint Substances 0.000 description 1
- 239000002245 particle Substances 0.000 description 1
- 239000011148 porous material Substances 0.000 description 1
- 238000002203 pretreatment Methods 0.000 description 1
- 108010020755 prolyl-glycyl-glycine Proteins 0.000 description 1
- 108010087846 prolyl-prolyl-glycine Proteins 0.000 description 1
- 108010053725 prolylvaline Proteins 0.000 description 1
- 239000013558 reference substance Substances 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 108010026333 seryl-proline Proteins 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 150000008163 sugars Chemical class 0.000 description 1
- 108010044292 tryptophyltyrosine Proteins 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
- 229920003169 water-soluble polymer Polymers 0.000 description 1
Images
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
- C07K7/04—Linear peptides containing only normal peptide links
- C07K7/06—Linear peptides containing only normal peptide links having 5 to 11 amino acids
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
- C07K7/04—Linear peptides containing only normal peptide links
- C07K7/08—Linear peptides containing only normal peptide links having 12 to 20 amino acids
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N27/00—Investigating or analysing materials by the use of electric, electrochemical, or magnetic means
- G01N27/62—Investigating or analysing materials by the use of electric, electrochemical, or magnetic means by investigating the ionisation of gases, e.g. aerosols; by investigating electric discharges, e.g. emission of cathode
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N30/00—Investigating or analysing materials by separation into components using adsorption, absorption or similar phenomena or using ion-exchange, e.g. chromatography or field flow fractionation
- G01N30/02—Column chromatography
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Molecular Biology (AREA)
- Biophysics (AREA)
- Genetics & Genomics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Immunology (AREA)
- Physics & Mathematics (AREA)
- Analytical Chemistry (AREA)
- General Physics & Mathematics (AREA)
- Pathology (AREA)
- Zoology (AREA)
- Toxicology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Electrochemistry (AREA)
- Gastroenterology & Hepatology (AREA)
- Peptides Or Proteins (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
The invention relates to a group of polypeptides for identifying mule skin-derived components in donkey-hide gelatin and donkey-hide gelatin-containing products, and a method for identifying mule skin-derived components in donkey-hide gelatin and donkey-hide gelatin-containing products by using the polypeptides through mass spectrometry, wherein the polypeptides in the polypeptide group have a specific sequence structure and a specific m/z value (including a specific parent ion and a pair of daughter ions), the sequences of the polypeptides are shown as SEQ ID NO. 1-36, the peptide sections SEQ ID NO.1-30 are common to horse skin and mule skin-derived gelatin, and the donkey skin gelatin, the mule skin-derived component and the mule skin-derived component are not present in boiled gelatin; the peptide segments SEQ ID NO.31-36 and m/z thereof are common to mule hide-derived glue and donkey-hide gelatin, and no mule hide-derived glue, pig hide-derived glue and horse hide-derived glue are produced.
Description
Technical Field
The invention belongs to the technical field of biology, and particularly relates to a group of polypeptides for identifying donkey-hide gelatin and mule skin-derived components in a donkey-hide gelatin product.
Background
Donkey-hide gelatin is a solid gelatin prepared by decocting and concentrating the skin of donkey of an equine family, is originally produced in Dong-A county of Shandong province, and has been used for nearly three thousand years. The donkey-hide gelatin is a traditional nourishing top-grade and blood-enriching holy medicine, is sweet and mild in taste, enters lung, liver and kidney channels, has the effects of enriching blood and stopping bleeding, nourishing yin and moistening dryness and the like, is used as both medicine and food, can enrich blood and nourish blood, whiten and beautify skin, resist aging, resist fatigue and improve immunity after being taken for a long time, and is widely applicable to people. Li Shizhen Bin (compendium of materia Medica) Bing: "E jiao" Ben Jing "the best quality. The Chinese herbal medicine has the following characteristics: 'Shandong donkey-hide gelatin' is known for its name. Donkey-hide gelatin is the most specific "genuine" herb among the herbs, and genuine donkey-hide gelatin must absorb Dong's water and be refined by the strange skill of the inheritor. The genuine donkey-hide gelatin has smooth surface, no pores, hard and crisp texture, bright and fine section, and fragments are in brown semitransparent shapes to light, and Li Shizhenzan has yellow color like amber color and black color like paint.
Pseudo-colla Corii Asini events were exposed as early as 1996. After many years, donkey-hide gelatin counterfeiting is not only not inhibited but also increasingly vigorous. These illegal enterprises use inferior materials such as cowhide, horse hide, pigskin, mule hide, etc. as leftovers to make fake donkey-hide gelatin by imitating donkey hide, and sell the fake donkey-hide gelatin to market after being supplemented with the inferior materials.
Part of the reasons that donkey-hide gelatin is frequently forbidden are lack of technical support for identification, and the source of the animal skin is difficult to identify because the characteristics of the animal skin are destroyed after the animal skin is decocted and dissolved. At present, no method for effectively identifying the donkey-hide gelatin component exists in China, and the donkey-hide gelatin component can be controlled only by a production source, so that a plurality of illegal enterprises are hollowed out.
A method for efficiently and accurately identifying the authenticity of the donkey-hide gelatin and products containing the donkey-hide gelatin is urgently needed. With the development of metabonomics technology, it became possible to directly identify animal-derived components using peptide biology.
Disclosure of Invention
The invention researches the polypeptide in donkey-hide gelatin and mule skin gelatin, verifies the polypeptide in cow skin gelatin, pig skin gelatin and horse skin gelatin, establishes the technology for identifying mule-derived components in donkey-hide gelatin and products containing donkey-hide gelatin from the polypeptide level, and fills the blank of the identification of donkey-hide gelatin and products containing donkey-hide gelatin at home and abroad.
The invention firstly relates to a group of polypeptides for detecting alone or in combination the mule skin source components in donkey-hide gelatin and donkey-hide gelatin-containing products, wherein the donkey-hide gelatin-containing products comprise, but are not limited to, donkey-hide gelatin cakes, donkey-hide gelatin pastes, donkey-hide gelatin slurries, donkey-hide gelatin oral liquids, donkey-hide gelatin sugars and donkey-hide gelatin blood-enriching particles, the polypeptide sequence is that the peptide sections 1-30 are mule skin source and horse skin source shared polypeptides, and the peptide sections 31-36 are mule skin source and donkey-hide gelatin shared polypeptides:
peptide fragment 1: SEQ ID NO. 1: LQTEAGEYSR
Peptide fragment 2: SEQ ID NO. 2: LVNDLTGQR, respectively;
peptide fragment 3: SEQ ID NO. 3: GSLGGGFSSGGFSGGSFSR, respectively;
peptide fragment 4: SEQ ID NO. 4: ELNMDNILVEIK, respectively;
peptide fragment 5: SEQ ID No. 5: FFDSFGDLSNPGAVMGN, respectively;
peptide fragment 6: SEQ ID NO. 6: PGAVMGNPK, respectively;
peptide fragment 7: SEQ ID NO. 7: DYAQVGR;
peptide fragment 8: SEQ ID NO. 8: SSSGQSSGFGR, respectively;
peptide fragment 9: SEQ ID NO. 9: MELETAGR;
peptide fragment 10: SEQ ID NO. 10: LPTGLPVSLLTLYLDNNK, respectively;
peptide fragment 11: SEQ ID NO. 11: YSSGSGAYSSGGR, respectively;
peptide fragment 12: SEQ ID NO. 12: ISGAGTGFGSR, respectively;
peptide fragment 13: SEQ ID NO. 13: GPSGEPGKPGDKGHAGLAGAR, respectively;
peptide fragment 14: SEQ ID No. 14: PVPHGTGSVPESPR, respectively;
peptide fragment 15: SEQ ID NO. 15: AEAESWYQSK, respectively;
peptide fragment 16: SEQ ID No. 16: VPSILDWVQK, respectively;
peptide fragment 17: SEQ ID NO. 17: VGYVSGWGR, respectively;
peptide fragment 18: SEQ ID NO. 18: DYAQVGR;
peptide fragment 19: SEQ ID NO. 19: NPVDQVQR;
peptide fragment 20: SEQ ID No. 20: QLEDELVSLQK, respectively;
peptide fragment 21: SEQ ID NO. 21: PGAVMGNPK, respectively;
peptide fragment 22: SEQ ID NO. 22: GSLGGGFSSGGFSGGSFSR, respectively;
peptide fragment 23: SEQ ID NO. 23: SLGGGFSSGGFSGGSFSR, respectively;
peptide fragment 24: SEQ ID No. 24: GETGPAGPAGPVGPVGAR, respectively;
peptide fragment 25: SEQ ID No. 25: GEPGPPGEAGAAGPAGNPGADGQPGAK, respectively;
peptide fragment 26: SEQ ID NO. 26: EGPVGLPGIDGRSGPIGPAGPR, respectively;
peptide fragment 27: SEQ ID NO. 27: GEPGPPGPAGFAGPPGADGQPGAK, respectively;
peptide fragment 28: SEQ ID NO. 28: ELNMDNILAEIK, respectively;
peptide fragment 29: SEQ ID NO. 29: VFVDLIR;
peptide fragment 30: SEQ ID No. 30: VVFHPDYQEVDIGLIK, respectively;
peptide fragment 31: SEQ ID NO. 31: GEPGGAGPVGPPGER, respectively;
peptide fragment 32: SEQ ID NO. 32: GSGGAAGVPGER, respectively;
peptide fragment 33: SEQ ID NO. 33: TGPAGAAGAR, respectively;
peptide fragment 34: SEQ ID No. 34: GLLESEDGKLPR R, respectively;
peptide fragment 35: SEQ ID NO. 35: TGPAGAAGAR, respectively;
peptide fragment 36: SEQ ID NO. 36: GLLESEDGK are provided.
The m/z is respectively as follows:
peptide fragment 1: 577.3;
peptide fragment 2: 508.3;
peptide fragment 3: 854.4, respectively;
peptide fragment 4: 715.9, respectively;
peptide fragment 5: 887.9, respectively;
peptide fragment 6: 435.7, respectively;
peptide fragment 7: 404.7;
peptide fragment 8: 528.7, respectively;
peptide fragment 9: 453.7, respectively;
peptide fragment 10: 986.5, respectively;
peptide fragment 11: 618.2, respectively;
peptide fragment 12: 505.2;
peptide fragment 13: 644.6, respectively;
peptide fragment 14: 472.9;
peptide fragment 15: 600.1;
peptide fragment 16: 593.2, respectively;
peptide fragment 17: 491.0, respectively;
peptide fragment 18: 404.9, respectively;
peptide fragment 19: 478.5, respectively;
peptide fragment 20: 651.7, respectively;
peptide fragment 21: 436.0;
peptide fragment 22: 854.9, respectively;
peptide fragment 23: 855.3, respectively;
peptide fragment 24: 523.5;
peptide fragment 25: 1142.5, respectively;
peptide fragment 26: 691.3, respectively;
peptide fragment 27: 701.3;
peptide fragment 28: 701.8, respectively;
peptide fragment 29: 431.2, respectively;
peptide fragment 30: 625.0, respectively;
peptide fragment 31: 683.3, respectively;
peptide fragment 32: 515.7, respectively;
peptide fragment 33: 414.7, respectively;
peptide fragment 34: 438.5;
peptide fragment 35: 414.9, respectively;
peptide fragment 36: 474.2.
the parent ion and partial daughter ion corresponding to 36 polypeptides are shown in the following table 1,
TABLE 1 mule skin-derived polypeptide sequences and their corresponding parent ions, partial daughter ions
The pretreatment method comprises the following steps:
(1) performing mass spectrum pretreatment on a sample to be detected to obtain polypeptide filtrate to be detected:
(2) detecting polypeptide components of a sample to be detected by mass spectrometry, and analyzing animal skin-derived components in the sample.
The mass spectrum pretreatment steps are as follows:
(1) homogenizing the sample to be tested into powder, weighing 0.1-0.5 g colla Corii Asini sample or 1.0-2.0g colla Corii Asini product, and adding 1% NH4HCO3Carrying out ultrasonic treatment on the solution for 10-30min to completely dissolve the sample, and fixing the volume to 50 mL;
(2) filtering the solution through a 0.22 mu m filter membrane;
(3) adding 10-20 mu L of Trypsin enzyme solution (1 mu g/mu L of Trypsin enzyme solution) into 100 mu L-200 mu L of the filtrate, carrying out enzymolysis at 37 ℃ for 16-18 hours, and waiting for detection on a computer.
The invention also relates to two mass spectrum methods for detecting the donkey-hide gelatin and the donkey-hide gelatin-containing products, wherein the mass spectrum method comprises the following steps,
mobile phase A: 0.05-0.2% formic acid-acetonitrile solution, mobile phase B: 0.05 to 0.2% formic acid-water,
flow rate: 0.1 to 0.5mL/min,
TOF scan range: 100-3000Da of the total weight of the material,
positive ion reaction mode, GS 1: 35, GS 2: 45, Curtain Gas: 35, ISVF: 5500, TEM: 500, DP: 100, CE: 10.
using AB SCIEX triple quadrupole mass spectrometry for detection,
mobile phase A: 0.05-0.2% formic acid-acetonitrile, mobile phase B: 0.05 to 0.2% formic acid-water,
flow rate: 0.1 to 0.5mL/min,
electrospray ion source, positive ion reaction mode, detection mode: MRM, spray voltage: 5500V, ion transfer tube temperature: 475 ℃; sheath gas pressure: 40; auxiliary gas pressure: 6.
the mule skin-derived component in the analysis sample is characterized in that the mule skin-derived component in the tissue sample can be judged to exist if the mass spectrum detection of the specific polypeptides of SEQ ID NO.1-30 exists and the mule skin-derived component does not exist when the mass spectrum result of the sample to be detected is compared with the mass spectrum spectrograms of the specific polypeptides of SEQ ID NO. 1-36 and the mass spectrum detection spectrograms of the specific polypeptides of SEQ ID NO.31-36 appear; if the mass spectrum detection of the specific polypeptide of SEQ ID NO.1-30 does not exist, judging that donkey skin derived components exist in the tissue sample; if the mass spectrometric detection of each specific polypeptide of SEQ ID No.31-36 does not exist, the tissue sample does not contain mule skin-derived and donkey skin-derived components.
Drawings
FIG. 1 shows a chromatogram characteristic diagram for detecting polypeptides shown in SEQ ID NO. 1-36 in donkey-hide gelatin
FIG. 2 is a chromatogram characteristic diagram for detecting polypeptides shown in SEQ ID NO. 1-36 in corium elephatis
FIG. 3 is a chromatogram characteristic diagram for detecting polypeptides shown in SEQ ID NO. 1-36 in oxhide glue
FIG. 4 is a chromatogram characteristic diagram for detecting the polypeptides shown in SEQ ID NO. 1-36 in pigskin glue
FIG. 5 is a chromatogram characteristic diagram for detecting polypeptides shown in SEQ ID NO. 1-36 in mule skin glue
FIG. 6 shows the mass spectrum of the representative characteristic peptide of mule-hide gelatin and donkey-hide gelatin in donkey-hide gelatin
FIG. 7 mass spectrogram of representative characteristic peptide of mule-hide gelatin and donkey-hide gelatin in mule-hide gelatin
FIG. 8 mass spectrum of representative characteristic peptide of mule hide gelatin and donkey hide gelatin in cow hide gelatin
FIG. 9 mass spectrum of representative characteristic peptide of mule hide gelatin and donkey hide gelatin in pigskin gelatin
FIG. 10 shows the mass spectra of representative characteristic peptide of mule-hide gelatin and donkey-hide gelatin in horse-hide gelatin
FIG. 11 shows the mass spectrum of representative characteristic peptide of mule-hide gelatin and horse-hide gelatin in donkey-hide gelatin
FIG. 12 is a mass spectrum of representative characteristic peptide of mule skin glue and mao skin glue in mule skin glue
FIG. 13 mass spectrum of representative characteristic peptide of mule hide gelatin and horse hide gelatin in cow hide gelatin
FIG. 14 mass spectrum of representative characteristic peptide of mule hide gelatin and horse hide gelatin in pigskin gelatin
FIG. 15 shows the mass spectra of representative characteristic peptide of mule hide glue and Ma hide glue in Ma hide glue
FIG. 16, mass spectrum of characteristic peptide of mule hide gelatin and donkey hide gelatin in sample 1
FIG. 17, the peptide mass spectrum of mule hide glue and massa hide glue in sample 1
FIG. 18, mass spectrum of horse hide glue characteristic peptide in sample 1
FIG. 19 is a mass spectrum of characteristic peptides of mule hide gelatin and donkey hide gelatin in control
FIG. 20 is a chart showing the characteristic peptide mass spectra of mule hide glue and massa hide glue in the control
Detailed Description
Example 1 screening of equine Peel rubber-specific Polypeptides
1. Through mass spectrometry analysis of pure product mule skin glue samples and donkey skin donkey hide glue samples, the protein Pilot software is utilized to search, compare and analyze mass spectrometry results, no mule skin glue specific characteristic polypeptide is found, but the most preferable common specific characteristic polypeptide sequence of mule skin glue and donkey skin donkey hide glue is determined, namely SEQ ID NO. 1-30.
2. Because mules are the offspring of horses and donkeys and have affinity, the same method is used for analyzing the polypeptide of the horse leather and the mule leather, but the special characteristic polypeptide of the mule leather is not found, but the special characteristic polypeptide sequence SEQ ID NO.31-36 shared by the most preferred mule leather and the mule leather is determined.
The specific mass spectrometry method is as follows:
firstly, performing mass spectrometry on a selected pure gelatin sample, wherein the steps comprise:
(I) sample pretreatment:
(1) weighing 0.1-0.5 g of pure sample homogenized into powder, and adding 1% NH4HCO3Carrying out ultrasonic treatment on the solution for 10-30min to completely dissolve the sample, and fixing the volume to 50 mL;
(2) filtering the solution through a 0.22 mu m filter membrane;
(3) adding 10-20 mu L of Trypsin enzyme solution (1 mu g/mu L of Trypsin enzyme solution) into 100 mu L-200 mu L of the filtrate, carrying out enzymolysis at 37 ℃ for 16-18 hours, and waiting for detection on a computer.
(II) performing on-machine detection,
mobile phase A: 0.05-0.2% formic acid-acetonitrile solution, mobile phase B: 0.05 to 0.2% formic acid-water,
flow rate: 0.1 to 0.5mL/min,
TOF scan range: 100-3000Da of the total weight of the material,
positive ion reaction mode, GS 1: 35, GS 2: 45, Curtain Gas: 35, ISVF: 5500, TEM: 500, DP: 100, CE: 10.
(2) the detection method by using AB SCIEX triple quadrupole mass spectrometry is as follows,
mobile phase A: 0.05-0.2% formic acid-acetonitrile, mobile phase B: 0.05 to 0.2% formic acid-water,
flow rate: 0.1 to 0.5mL/min,
electrospray ion source, positive ion reaction mode, detection mode: MRM, spray voltage: 5500V, ion transfer tube temperature: 475 ℃; sheath gas pressure: 40; auxiliary gas pressure: 6.
secondly, according to the mass spectrum result of the pure gelatin sample, the protein Pilot software is utilized to carry out retrieval comparison analysis on the mass spectrum result,
(1) screening to obtain a common special characteristic polypeptide group which really exists in mule hide glue and donkey-hide glue, wherein the sequence information of each polypeptide in the group is as shown in SEQ ID NO. 1-30;
(2) screening to obtain a common special characteristic polypeptide group which really exists in mule hide glue and horse hide glue, wherein the sequence information of each polypeptide in the group is as follows SEQ ID NO. 31-36:
peptide fragment 1: SEQ ID NO. 1: LQTEAGEYSR
Peptide fragment 2: SEQ ID NO. 2: LVNDLTGQR, respectively;
peptide fragment 3: SEQ ID NO. 3: GSLGGGFSSGGFSGGSFSR, respectively;
peptide fragment 4: SEQ ID NO. 4: ELNMDNILVEIK, respectively;
peptide fragment 5: SEQ ID No. 5: FFDSFGDLSNPGAVMGN, respectively;
peptide fragment 6: SEQ ID NO. 6: PGAVMGNPK, respectively;
peptide fragment 7: SEQ ID NO. 7: DYAQVGR;
peptide fragment 8: SEQ ID NO. 8: SSSGQSSGFGR, respectively;
peptide fragment 9: SEQ ID NO. 9: MELETAGR;
peptide fragment 10: SEQ ID NO. 10: LPTGLPVSLLTLYLDNNK, respectively;
peptide fragment 11: SEQ ID NO. 11: YSSGSGAYSSGGR, respectively;
peptide fragment 12: SEQ ID NO. 12: ISGAGTGFGSR, respectively;
peptide fragment 13: SEQ ID NO. 13: GPSGEPGKPGDKGHAGLAGAR, respectively;
peptide fragment 14: SEQ ID No. 14: PVPHGTGSVPESPR, respectively;
peptide fragment 15: SEQ ID NO. 15: AEAESWYQSK, respectively;
peptide fragment 16: SEQ ID No. 16: VPSILDWVQK, respectively;
peptide fragment 17: SEQ ID NO. 17: VGYVSGWGR, respectively;
peptide fragment 18: SEQ ID NO. 18: DYAQVGR;
peptide fragment 19: SEQ ID NO. 19: NPVDQVQR;
peptide fragment 20: SEQ ID No. 20: QLEDELVSLQK, respectively;
peptide fragment 21: SEQ ID NO. 21: PGAVMGNPK, respectively;
peptide fragment 22: SEQ ID NO. 22: GSLGGGFSSGGFSGGSFSR, respectively;
peptide fragment 23: SEQ ID NO. 23: SLGGGFSSGGFSGGSFSR, respectively;
peptide fragment 24: SEQ ID No. 24: GETGPAGPAGPVGPVGAR, respectively;
peptide fragment 25: SEQ ID No. 25: GEPGPPGEAGAAGPAGNPGADGQPGAK, respectively;
peptide fragment 26: SEQ ID NO. 26: EGPVGLPGIDGRSGPIGPAGPR, respectively;
peptide fragment 27: SEQ ID NO. 27: GEPGPPGPAGFAGPPGADGQPGAK, respectively;
peptide fragment 28: SEQ ID NO. 28: ELNMDNILAEIK, respectively;
peptide fragment 29: SEQ ID NO. 29: VFVDLIR;
peptide fragment 30: SEQ ID No. 30: VVFHPDYQEVDIGLIK, respectively;
peptide fragment 31: SEQ ID NO. 31: GEPGGAGPVGPPGER, respectively;
peptide fragment 32: SEQ ID NO. 32: GSGGAAGVPGER, respectively;
peptide fragment 33: SEQ ID NO. 33: TGPAGAAGAR, respectively;
peptide fragment 34: SEQ ID No. 34: GLLESEDGKLPR R, respectively;
peptide fragment 35: SEQ ID NO. 35: TGPAGAAGAR, respectively;
peptide fragment 36: SEQ ID NO. 36: GLLESEDGK are provided.
The values of m/z for the 36 polypeptides are as follows:
peptide fragment 1: 577.3;
peptide fragment 2: 508.3;
peptide fragment 3: 854.4, respectively;
peptide fragment 4: 715.9, respectively;
peptide fragment 5: 887.9, respectively;
peptide fragment 6: 435.7, respectively;
peptide fragment 7: 404.7;
peptide fragment 8: 528.7, respectively;
peptide fragment 9: 453.7, respectively;
peptide fragment 10: 986.5, respectively;
peptide fragment 11: 618.2, respectively;
peptide fragment 12: 505.2;
peptide fragment 13: 644.6, respectively;
peptide fragment 14: 472.9;
peptide fragment 15: 600.1;
peptide fragment 16: 593.2, respectively;
peptide fragment 17: 491.0, respectively;
peptide fragment 18: 404.9, respectively;
peptide fragment 19: 478.5, respectively;
peptide fragment 20: 651.7, respectively;
peptide fragment 21: 436.0;
peptide fragment 22: 854.9, respectively;
peptide fragment 23: 855.3, respectively;
peptide fragment 24: 523.5;
peptide fragment 25: 1142.5, respectively;
peptide fragment 26: 691.3, respectively;
peptide fragment 27: 701.3;
peptide fragment 28: 701.8, respectively;
peptide fragment 29: 431.2, respectively;
peptide fragment 30: 625.0, respectively;
peptide fragment 31: 683.3, respectively;
peptide fragment 32: 515.7, respectively;
peptide fragment 33: 414.7, respectively;
peptide fragment 34: 438.5;
peptide fragment 35: 414.9, respectively;
peptide fragment 36: 474.2.
finally, donkey-hide gelatin samples, oxhide gelatin, pigskin gelatin, horse hide gelatin and mule hide gelatin samples are processed and detected by the same method, mass spectrum detection results are matched, and the results show that each polypeptide sample shown in SEQ ID No.1-30 does not exist in the oxhide gelatin and the pigskin gelatin; each of the polypeptide samples shown in SEQ ID nos. 31 to 36 does not exist in bovine hide gelatin or porcine hide gelatin.
FIGS. 1 to 5 are chromatogram characteristic diagrams of the polypeptide SEQ ID NO.1 to 36 detected in donkey-hide gelatin, horse hide gelatin, cow hide gelatin, pig hide gelatin and mule hide gelatin samples, and it can be seen that chromatogram peaks of SEQ ID NO.1 to 36 are not detected in cow hide gelatin and pig hide gelatin samples.
Fig. 6-10 show mass spectra of one of the representative characteristic peptide segments (SEQ ID No.25) shared by mule hide glue and donkey-hide glue in samples of mule hide glue, horse hide glue, cow hide glue, pig hide glue and mule hide glue, respectively, showing that the representative characteristic peptide segment shared by mule hide glue and donkey-hide glue is obviously present in the spectra of mule hide glue and donkey-hide glue, but is absent in the spectra of cow hide glue, pig hide glue and horse hide glue.
Fig. 11-15 show mass spectra of one of representative characteristic peptide segments (SEQ ID No.34) shared by mule hide glue and horse hide glue in samples of mule hide glue, horse hide glue, cow hide glue, pig hide glue and mule hide glue, respectively, showing that the representative characteristic peptide segment shared by mule hide glue and horse hide glue is obviously present in the mule hide glue and horse hide glue spectra, but is absent in the samples of mule hide glue, pig hide glue and donkey hide glue.
Example 2, no specific donkey-hide gelatin sample was tested to determine whether it was a fake product of horse hide gelatin
And carrying out mass spectrum analysis on the examined donkey-hide gelatin, the donkey-hide gelatin product sample and the commercially available donkey-hide gelatin product to determine whether the donkey-hide gelatin is a pure donkey-hide gelatin.
The method for treating and detecting the sample to be tested was the same as that in example 1
Step (I) sample pretreatment step:
(1) homogenizing the sample to be tested into powder, weighing 0.1g colla Corii Asini sample or 2.0g colla Corii Asini product, adding 1% NH4HCO3Carrying out ultrasonic treatment on the solution for 10-30min to completely dissolve the sample, and fixing the volume to 50 mL;
(2) filtering the solution through a 0.22 mu m filter membrane;
(3) adding 10 μ L of Trypsin enzyme solution (1 μ g/μ L of Trypsin enzyme solution) into 100 μ L of the above filtrate, performing enzymolysis at 37 deg.C for 16-18 hr, and performing detection on the machine.
In the step (II), the machine is used for detection,
mobile phase A: 0.1% formic acid-acetonitrile, mobile phase B: 0.1 percent of formic acid-water,
flow rate: the concentration of the active carbon is 0.25mL/min,
TOF scan range: 350-1500Da,
positive ion reaction mode, GS 1: 35, GS 2: 45, Curtain Gas: 35, ISVF: 5500, TEM: 500, DP: 100, CE: 10.
using AB SCIEX triple quadrupole mass spectrometry for detection,
mobile phase A: 0.1% formic acid-acetonitrile, mobile phase B: 0.1 percent of formic acid-water,
flow rate: 0.3mL/min of the water-soluble polymer,
electrospray ion source, positive ion reaction mode, detection mode: MRM, spray voltage: 5500V, ion transfer tube temperature: 475 ℃; sheath gas pressure: 40; auxiliary gas pressure: 6.
comparing the detection results with the mass spectrum of each specific polypeptide in example 1,
(1) when the mass spectrum detection spectrogram of each specific polypeptide of SEQ ID NO.31-36 described in example 1 appears, if the mass spectrum detection of the specific polypeptides of SEQ ID NO.1-30 exists and the specific polypeptide of the equine derived component is detected to be absent independently, the existence of the tissue sample can be judgedMule skin derived component(ii) a If the mass spectrum detection of the specific polypeptide of SEQ ID NO.1-30 exists, the existence of the tissue sample can be judgedDonkey hide derived component;
(2) And if the mass spectrum detection of each specific polypeptide of SEQ ID NO.31-36 does not exist, the tissue sample does not have mule skin-derived components and horse skin-derived components.
Sample 1 detected only mule skin-derived components:
selecting the two common characteristic polypeptides (SEQ ID No.12 and SEQ ID No.25) of the mule hide glue and the donkey-hide gelatin, the two common characteristic polypeptides (SEQ ID No.31 and SEQ ID No.34) of the mule hide glue and the donkey-hide gelatin and the known two characteristic polypeptides of the mule hide glue as references, detecting a chromatographic peak (see fig. 16) of the two common characteristic polypeptides of the mule hide glue and the donkey-hide gelatin in the sample 1 under the same detection condition, detecting a chromatographic peak (see fig. 17) of the two common characteristic polypeptides of the mule hide glue and the donkey-hide gelatin, and not detecting a chromatographic peak (see fig. 18) of the specific polypeptides of the donkey-hide gelatin; as can be seen, sample 1 contained only mule skin source components.
The reference substance only detects donkey skin-derived ingredients, and no mule skin-derived ingredients are detected:
the characteristic polypeptides (SEQ ID No.4 and SEQ ID No.25) shared by the two mule hide glues and the donkey-hide glue in the example 1 and the characteristic polypeptides (SEQ ID No.34 and SEQ ID No.36) shared by the two mule hide glues and the donkey-hide glue are selected as references, and under the same detection condition, the chromatographic peak of the characteristic polypeptides (shown in figure 19) shared by the mule hide glue and the donkey-hide glue is detected in the mahonia-jongji product produced by the reference product of the Dong donkey-hide glue, and the chromatographic peak of the characteristic polypeptides (shown in figure 20) shared by the mule hide glue and the donkey-hide glue is not detected.
Finally, it should be noted that the above examples are only used to help those skilled in the art understand the essence of the present invention, and should not be used to limit the protection scope of the present invention.
SEQUENCE LISTING
<110> Shandong entry-exit inspection and quarantine technical center
<120> a polypeptide for identifying donkey-hide gelatin and mule skin-derived components in donkey-hide gelatin products
<160> 36
<170> PatentIn version 3.3
<210> 1
<211> 10
<212> PRT
<213> Artificial sequence
<400> 1
Leu Gln Thr Glu Ala Gly Glu Tyr Ser Arg
1 5 10
<210> 2
<211> 9
<212> PRT
<213> Artificial sequence
<400> 2
Leu Val Asn Asp Leu Thr Gly Gln Arg
1 5
<210> 3
<211> 19
<212> PRT
<213> Artificial sequence
<400> 3
Gly Ser Leu Gly Gly Gly Phe Ser Ser Gly Gly Phe Ser Gly Gly Ser
1 5 10 15
Phe Ser Arg
<210> 4
<211> 12
<212> PRT
<213> Artificial sequence
<400> 4
Glu Leu Asn Met Asp Asn Ile Leu Val Glu Ile Lys
1 5 10
<210> 5
<211> 17
<212> PRT
<213> Artificial sequence
<400> 5
Phe Phe Asp Ser Phe Gly Asp Leu Ser Asn Pro Gly Ala Val Met Gly
1 5 10 15
Asn
<210> 6
<211> 9
<212> PRT
<213> Artificial sequence
<400> 6
Pro Gly Ala Val Met Gly Asn Pro Lys
1 5
<210> 7
<211> 7
<212> PRT
<213> Artificial sequence
<400> 7
Asp Tyr Ala Gln Val Gly Arg
1 5
<210> 8
<211> 11
<212> PRT
<213> Artificial sequence
<400> 8
Ser Ser Ser Gly Gln Ser Ser Gly Phe Gly Arg
1 5 10
<210> 9
<211> 8
<212> PRT
<213> Artificial sequence
<400> 9
Met Glu Leu Glu Thr Ala Gly Arg
1 5
<210> 10
<211> 18
<212> PRT
<213> Artificial sequence
<400> 10
Leu Pro Thr Gly Leu Pro Val Ser Leu Leu Thr Leu Tyr Leu Asp Asn
1 5 10 15
Asn Lys
<210> 11
<211> 13
<212> PRT
<213> Artificial sequence
<400> 11
Tyr Ser Ser Gly Ser Gly Ala Tyr Ser Ser Gly Gly Arg
1 5 10
<210> 12
<211> 11
<212> PRT
<213> Artificial sequence
<400> 12
Ile Ser Gly Ala Gly Thr Gly Phe Gly Ser Arg
1 5 10
<210> 13
<211> 21
<212> PRT
<213> Artificial sequence
<400> 13
Gly Pro Ser Gly Glu Pro Gly Lys Pro Gly Asp Lys Gly His Ala Gly
1 5 10 15
Leu Ala Gly Ala Arg
20
<210> 14
<211> 14
<212> PRT
<213> Artificial sequence
<400> 14
Pro Val Pro His Gly Thr Gly Ser Val Pro Glu Ser Pro Arg
1 5 10
<210> 15
<211> 10
<212> PRT
<213> Artificial sequence
<400> 15
Ala Glu Ala Glu Ser Trp Tyr Gln Ser Lys
1 5 10
<210> 16
<211> 10
<212> PRT
<213> Artificial sequence
<400> 16
Val Pro Ser Ile Leu Asp Trp Val Gln Lys
1 5 10
<210> 17
<211> 9
<212> PRT
<213> Artificial sequence
<400> 17
Val Gly Tyr Val Ser Gly Trp Gly Arg
1 5
<210> 18
<211> 7
<212> PRT
<213> Artificial sequence
<400> 18
Asp Tyr Ala Gln Val Gly Arg
1 5
<210> 19
<211> 8
<212> PRT
<213> Artificial sequence
<400> 19
Asn Pro Val Asp Gln Val Gln Arg
1 5
<210> 20
<211> 11
<212> PRT
<213> Artificial sequence
<400> 20
Gln Leu Glu Asp Glu Leu Val Ser Leu Gln Lys
1 5 10
<210> 21
<211> 9
<212> PRT
<213> Artificial sequence
<400> 21
Pro Gly Ala Val Met Gly Asn Pro Lys
1 5
<210> 22
<211> 19
<212> PRT
<213> Artificial sequence
<400> 22
Gly Ser Leu Gly Gly Gly Phe Ser Ser Gly Gly Phe Ser Gly Gly Ser
1 5 10 15
Phe Ser Arg
<210> 23
<211> 18
<212> PRT
<213> Artificial sequence
<400> 23
Ser Leu Gly Gly Gly Phe Ser Ser Gly Gly Phe Ser Gly Gly Ser Phe
1 5 10 15
Ser Arg
<210> 24
<211> 18
<212> PRT
<213> Artificial sequence
<400> 24
Gly Glu Thr Gly Pro Ala Gly Pro Ala Gly Pro Val Gly Pro Val Gly
1 5 10 15
Ala Arg
<210> 25
<211> 27
<212> PRT
<213> Artificial sequence
<400> 25
Gly Glu Pro Gly Pro Pro Gly Glu Ala Gly Ala Ala Gly Pro Ala Gly
1 5 10 15
Asn Pro Gly Ala Asp Gly Gln Pro Gly Ala Lys
20 25
<210> 26
<211> 22
<212> PRT
<213> Artificial sequence
<400> 26
Glu Gly Pro Val Gly Leu Pro Gly Ile Asp Gly Arg Ser Gly Pro Ile
1 5 10 15
Gly Pro Ala Gly Pro Arg
20
<210> 27
<211> 24
<212> PRT
<213> Artificial sequence
<400> 27
Gly Glu Pro Gly Pro Pro Gly Pro Ala Gly Phe Ala Gly Pro Pro Gly
1 5 10 15
Ala Asp Gly Gln Pro Gly Ala Lys
20
<210> 28
<211> 12
<212> PRT
<213> Artificial sequence
<400> 28
Glu Leu Asn Met Asp Asn Ile Leu Ala Glu Ile Lys
1 5 10
<210> 29
<211> 7
<212> PRT
<213> Artificial sequence
<400> 29
Val Phe Val Asp Leu Ile Arg
1 5
<210> 30
<211> 16
<212> PRT
<213> Artificial sequence
<400> 30
Val Val Phe His Pro Asp Tyr Gln Glu Val Asp Ile Gly Leu Ile Lys
1 5 10 15
<210> 31
<211> 15
<212> PRT
<213> Artificial sequence
<400> 31
Gly Glu Pro Gly Gly Ala Gly Pro Val Gly Pro Pro Gly Glu Arg
1 5 10 15
<210> 32
<211> 12
<212> PRT
<213> Artificial sequence
<400> 32
Gly Ser Gly Gly Ala Ala Gly Val Pro Gly Glu Arg
1 5 10
<210> 33
<211> 10
<212> PRT
<213> Artificial sequence
<400> 33
Thr Gly Pro Ala Gly Ala Ala Gly Ala Arg
1 5 10
<210> 34
<211> 13
<212> PRT
<213> Artificial sequence
<400> 34
Gly Leu Leu Glu Ser Glu Asp Gly Lys Leu Pro Arg Arg
1 5 10
<210> 35
<211> 10
<212> PRT
<213> Artificial sequence
<400> 35
Thr Gly Pro Ala Gly Ala Ala Gly Ala Arg
1 5 10
<210> 36
<211> 9
<212> PRT
<213> Artificial sequence
<400> 36
Gly Leu Leu Glu Ser Glu Asp Gly Lys
1 5
Claims (2)
1. The application of a group of polypeptide groups in the preparation of a detection product for detecting mule skin-derived components in donkey-hide gelatin products,
the colla Corii Asini-containing product comprises colla Corii Asini cake, colla Corii Asini paste, colla Corii Asini slurry, colla Corii Asini oral liquid, colla Corii Asini sugar, and colla Corii Asini blood tonifying granule;
the polypeptide group is as follows:
(1) peptide sections SEQ ID NO.4, 12 and 25 are mule skin source and donkey skin source shared polypeptide,
peptide fragment 4: SEQ ID NO. 4: ELNMDNILVEIK, respectively;
peptide fragment 12: SEQ ID NO. 12: ISGAGTGFGSR, respectively;
peptide fragment 25: SEQ ID No. 25: GEPGPPGEAGAAGPAGNPGADGQPGAK, respectively;
(2) peptide fragments SEQ ID No.31, 34, 36 are mule-hide-source and horse-hide-source shared polypeptides:
peptide fragment 31: SEQ ID NO. 31: GEPGGAGPVGPPGER, respectively;
peptide fragment 34: SEQ ID No. 34: GLLESEDGKLPRR, respectively;
peptide fragment 36: SEQ ID NO. 36: GLLESEDGK, respectively;
the detection is to detect whether the donkey-hide gelatin product sample contains mule skin-derived components, if the mule skin-derived components appear in the sample:
1) when mass spectrum detection spectrograms of the polypeptides shown in SEQ ID NO.31, 34 and 36 are carried out; and is
2) When mass spectrum detection spectrograms of the polypeptides shown in SEQ ID NO.4, 12 and 25 are carried out; and is
3) Detecting the absence of the polypeptide specific to the equine cortex component alone;
the existence of mule skin-derived components in the sample can be judged.
2. A detection method for detecting whether mule skin-derived components are contained in donkey-hide gelatin and products containing the donkey-hide gelatin comprises the following steps:
step (1), performing mass spectrum pretreatment on a sample to be detected to obtain a polypeptide filtrate to be detected:
step (2), detecting the polypeptide filtrate obtained in the step (1) by mass spectrometry, and detecting whether a sample to be detected contains a mass spectrum peak of the peptide fragment of claim 1;
as in the sample described:
1) when mass spectrum detection spectrograms of the polypeptides shown in SEQ ID NO.31, 34 and 36 are carried out; and is
2) When mass spectrum detection spectrograms of the polypeptides shown in SEQ ID NO.4, 12 and 25 are carried out; and is
3) Detecting the absence of the polypeptide specific to the equine cortex component alone;
judging the existence of mule skin-derived components in the sample;
the step (1) of performing mass spectrum pretreatment on a sample to be detected to obtain a polypeptide filtrate to be detected comprises the following steps:
1) homogenizing a sample to be tested into powder, weighing 0.1-0.5 g of donkey-hide gelatin sample or 1.0-2.0g of donkey-hide gelatin-containing product, and adding 1% NH4HCO3Carrying out ultrasonic treatment on the solution for 10-30min to completely dissolve the sample, and fixing the volume to 50 mL;
2) filtering the solution through a 0.22 mu m filter membrane to obtain filtrate;
3) adding 10-20 muL of Trypsin enzyme solution of 1 mug/muL into 100 muL-200 muL of the filtrate, performing enzymolysis at 37 ℃ for 16-18 hours, and waiting for on-machine detection;
step (2) the method of examining the polypeptide filtrate obtained in step (1) by mass spectrometry is the following method A or method B:
the method A comprises the following steps: detecting whether the polypeptide filtrate contains a mass spectrum peak of the peptide fragment of claim 1 by using AB SCIEX tripleTOF 5605600 mass spectrum,
the computer-operating parameters are as follows:
mobile phase A: 0.05-0.2% formic acid-acetonitrile solution, mobile phase B: 0.05 to 0.2% formic acid-water,
flow rate: 0.1 to 0.5mL/min,
TOF scan range: 100-3000Da of the total weight of the material,
positive ion reaction mode, GS 1: 35, GS 2: 45, Curtain Gas: 35, ISVF: 5500, TEM: 500, DP: 100, CE: 10;
the method B comprises the following steps: detecting whether the polypeptide filtrate contains a mass spectrum peak of the peptide fragment of claim 1 by AB SCIEX triple quadrupole mass spectrometry,
the computer-operating parameters are as follows:
mobile phase A: 0.05-0.2% formic acid-acetonitrile, mobile phase B: 0.05 to 0.2% formic acid-water,
flow rate: 0.1 to 0.5mL/min,
electrospray ion source, positive ion reaction mode, detection mode: MRM, spray voltage: 5500V, ion transfer tube temperature: 475 ℃; sheath gas pressure: 40; auxiliary gas pressure: 6.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201811245616.XA CN109293742B (en) | 2018-10-24 | 2018-10-24 | Polypeptide for identifying donkey-hide gelatin and mule skin-derived component in donkey-hide gelatin product |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201811245616.XA CN109293742B (en) | 2018-10-24 | 2018-10-24 | Polypeptide for identifying donkey-hide gelatin and mule skin-derived component in donkey-hide gelatin product |
Publications (2)
Publication Number | Publication Date |
---|---|
CN109293742A CN109293742A (en) | 2019-02-01 |
CN109293742B true CN109293742B (en) | 2022-04-26 |
Family
ID=65157693
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201811245616.XA Active CN109293742B (en) | 2018-10-24 | 2018-10-24 | Polypeptide for identifying donkey-hide gelatin and mule skin-derived component in donkey-hide gelatin product |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN109293742B (en) |
Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN104280468A (en) * | 2013-07-12 | 2015-01-14 | 山东东阿阿胶股份有限公司 | Method for detecting horse-breed and mule-breed derived ingredients in gelatin-type traditional Chinese medicine and products |
CN105273061A (en) * | 2015-10-09 | 2016-01-27 | 东阿阿胶股份有限公司 | Common polypeptide in animal glue and application thereof in detection |
CN105842375A (en) * | 2016-03-29 | 2016-08-10 | 山东出入境检验检疫局检验检疫技术中心 | Polypeptide group for identification of donkey components in gelatin and products thereof, |
CN106198790A (en) * | 2016-07-01 | 2016-12-07 | 山东省食品药品检验研究院 | A kind of horse and mule common characteristic polypeptide and application thereof |
-
2018
- 2018-10-24 CN CN201811245616.XA patent/CN109293742B/en active Active
Patent Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN104280468A (en) * | 2013-07-12 | 2015-01-14 | 山东东阿阿胶股份有限公司 | Method for detecting horse-breed and mule-breed derived ingredients in gelatin-type traditional Chinese medicine and products |
CN105273061A (en) * | 2015-10-09 | 2016-01-27 | 东阿阿胶股份有限公司 | Common polypeptide in animal glue and application thereof in detection |
CN105842375A (en) * | 2016-03-29 | 2016-08-10 | 山东出入境检验检疫局检验检疫技术中心 | Polypeptide group for identification of donkey components in gelatin and products thereof, |
CN106198790A (en) * | 2016-07-01 | 2016-12-07 | 山东省食品药品检验研究院 | A kind of horse and mule common characteristic polypeptide and application thereof |
Non-Patent Citations (11)
Title |
---|
A rapid and simple UPLC-MS/MS method using collagen marker peptides for identification of porcine gelatin;S. Guo等;《RSC Adv.》;20180119;第8卷;第3768-3773页 * |
Detection of unlabelled meat in meat products using proteomics and genomics;A. Charlton等;《The Food and Environment Research Agency》;20140227;第1-27页 * |
Determination and Quantification of Collagen Types in Tissues Using HPLC-MS/MS;S. Pataridis;《Current Analytical Chemistry》;20091001;第5卷;第316-323页 * |
Differential expression of equine muscle biopsy proteins during normal training and intensified training in young standardbred horses using proteomics technology;F. G. Bouwman等;《Comparative Biochemistry and Physiology, Part D》;20091113;第5卷(第1期);第55-64页 * |
Effect of surface-adsorbed proteins and phosphorylation inhibitor AG18 on intracellular protein expression in adherent macrophages;S. T. Zuckerman等;《Biomaterials》;20060731;第27卷(第20期);第3745-3757页 * |
Identification of alpha-tropomyosin as a target self-selfantigen;F. Mor等;《Eur. J. Immunol. 2002》;20020117;第32卷(第2期);第356-365页 * |
Identification of novel peptides for horse meat speciation in highly processed foodstuffs;A. J. Claydon等;《Food Additives & Contaminants: Part A》;20150814;第32卷(第10期);第1718-1729页 * |
Poppea’s bath liquor: The secret proteome of she-donkey’s milk;V. Cunsolo等;《JOURNAL OF PROTEOMICS》;20110530;第74卷(第10期);第2083-2099页 * |
QC or Bust: Performance Assessment for Quantitative Plasma Proteomics by MRM;Andrew Percy;《UVic-Genome BC Proteomics Centre》;20140407;第1-23页 * |
Rapid Detection of Peptide Markers for Authentication Purposes in Raw and Cooked Meat Using Ambient Liquid Extraction Surface Analysis Mass Spectrometry;M. Montowska等;《Anal. Chem》;20040926;第86卷(第20期);第10257-10265页 * |
特征肽段检测技术用于胶类药材专属性鉴别方法研究;程显隆等;《中国药学杂志》;20150122;第50卷(第2期);第104-108页 * |
Also Published As
Publication number | Publication date |
---|---|
CN109293742A (en) | 2019-02-01 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN109280077B (en) | Polypeptide for identifying donkey-hide gelatin and pigskin-derived components in donkey-hide gelatin product | |
CN111825744B (en) | Short peptides for identifying donkey-hide gelatin and bovine-derived components in donkey-hide gelatin product | |
CN105842375B (en) | The polypeptide of donkey derived component in one group of discriminating donkey-hide gelatin and its product | |
Rodríguez-Nuñez et al. | Peptide generation in the processing of dry-cured ham | |
CN112213401B (en) | Donkey-derived characteristic peptide of donkey-hide gelatin and donkey-hide gelatin product and identification method of donkey-hide gelatin product | |
CN113004374B (en) | Deer glue characteristic peptide and method for identifying deer glue contained in sample to be detected | |
CN110272935A (en) | A kind of peanut antioxidant peptide and preparation method thereof of high pressure assistance enzymolysis preparation | |
CN112782291A (en) | Method for identifying donkey-derived components in donkey-hide gelatin and preparation thereof | |
CN109293741B (en) | Polypeptide for identifying donkey-hide gelatin and horse hide derived components in donkey-hide gelatin product | |
CN107955063A (en) | A kind of feature polypeptide using from Clonorchiasis Sinensis differentiates the method that U.S.'s meat is joined | |
CN109293742B (en) | Polypeptide for identifying donkey-hide gelatin and mule skin-derived component in donkey-hide gelatin product | |
CN107525873B (en) | Method for qualitatively analyzing gelatin source in donkey-hide gelatin cake | |
CN112898400A (en) | Characteristic peptide segment capable of distinguishing antler glue and deer skin glue and detection method thereof | |
CN101007841A (en) | Method for separating and purifying ACE inhibition peptide from rice draff and active peptide obtained therefor | |
CN110105440B (en) | Special characteristic peptide fragment and method for identifying sea cucumber species by using same | |
CN111303263A (en) | Earthworm characteristic polypeptide and application thereof in species identification of earthworm medicinal materials | |
WO2022016809A1 (en) | Endothelium corneum gigeriae galli specific polypeptide and application thereof in identification of endothelium corneum gigeriae galli | |
CN108503686A (en) | A kind of extracting method and its special extract of plant total protein | |
CN105987888B (en) | A method of it fishes from mixture and screens active constituent monomer or active constituent group | |
CN107190040A (en) | A kind of ring shrimp anti-oxidation peptide and preparation method thereof | |
CN111707756A (en) | Method for evaluating stability of debitterized and decolored soybean peptide production process | |
CN115197298B (en) | Peptide fragment composition for relatively quantitatively analyzing porcine cytochrome P450 enzyme CYP2E1 and application thereof | |
CN112903791B (en) | Method for identifying gum medicinal material based on chemical oscillation fingerprint spectrum technology | |
CN118207280A (en) | Pigeon meat flavor peptide screening and study on flavor development mechanism of pigeon meat flavor peptide and receptor T1R1-T1R3 | |
CN116183798A (en) | Detection method of characteristic polypeptide in Pianzaihuang |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
GR01 | Patent grant | ||
GR01 | Patent grant | ||
CP03 | Change of name, title or address |
Address after: 266000 No. 83, Xinyue Road, Qingdao, Shandong Patentee after: Qingdao Customs Technology Center Country or region after: China Address before: Qingdao City, Shandong province 266002 qutangxia Road No. 70 Patentee before: Inspection and Quarantine Technology Center of Shandong entry exit inspection and Quarantine Bureau Country or region before: China |
|
CP03 | Change of name, title or address |